Home
>
National Drug Code (NDC)
>
Divalproex Sodium
Divalproex Sodium - 0615-7533-01 - (Divalproex Sodium)
Drug Information of Divalproex Sodium
| Product NDC: | 0615-7533 |
| Proprietary Name: | Divalproex Sodium |
| Non Proprietary Name: | Divalproex Sodium |
| Active Ingredient(s): | 500 mg/1 & nbsp; Divalproex Sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Divalproex Sodium
| Product NDC: | 0615-7533 |
| Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078182 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110121 |
Package Information of Divalproex Sodium
| Package NDC: | 0615-7533-01 |
| Package Description: | 10 BLISTER PACK in 1 CARTON (0615-7533-01) > 30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0615-7533-39) |
NDC Information of Divalproex Sodium
| NDC Code | 0615-7533-01 |
| Proprietary Name | Divalproex Sodium |
| Package Description | 10 BLISTER PACK in 1 CARTON (0615-7533-01) > 30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0615-7533-39) |
| Product NDC | 0615-7533 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Divalproex Sodium |
| Dosage Form Name | TABLET, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20110121 |
| Marketing Category Name | ANDA |
| Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
| Substance Name | DIVALPROEX SODIUM |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |
